Core Laboratories Stock Forecast, Price & News

Core Laboratories (NYSE:CLB) Frequently Asked Questions

Is Core Laboratories a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 3 sell ratings and 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories or view top-rated stocks.

What stocks does MarketBeat like better than Core Laboratories?

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Core Laboratories.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Thursday, October 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its quarterly earnings results on Wednesday, July, 28th. The oil and gas company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by $0.01. The oil and gas company earned $118.75 million during the quarter, compared to analyst estimates of $118.85 million. Core Laboratories had a net margin of 7.32% and a trailing twelve-month return on equity of 27.46%.
View Core Laboratories' earnings history.

How has Core Laboratories' stock price been impacted by Coronavirus?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 175.7% and is now trading at $30.13.
View which stocks have been most impacted by COVID-19.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 30th. Stockholders of record on Monday, August 9th will be given a dividend of $0.01 per share on Tuesday, August 24th. This represents a $0.04 annualized dividend and a yield of 0.13%. The ex-dividend date is Friday, August 6th.
View Core Laboratories' dividend history.

Is Core Laboratories a good dividend stock?

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.13%. Core Laboratories has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Core Laboratories is 5.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.42% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its third quarter 2021 earnings guidance on Wednesday, August, 4th. The company provided earnings per share guidance of $0.190-$0.210 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.230. The company issued revenue guidance of $122 million-$126 million, compared to the consensus revenue estimate of $125.67 million.

What price target have analysts set for CLB?

7 analysts have issued 1-year target prices for Core Laboratories' stock. Their forecasts range from $17.50 to $36.00. On average, they anticipate Core Laboratories' share price to reach $26.79 in the next year. This suggests that the stock has a possible downside of 11.1%.
View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts.

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:

• Lawrence V. Bruno, Chairman-Supervisory Board, President, CEO & COO
• Christopher S. Hill, Chief Financial Officer & Senior Vice President
• Mark F. Elvig, Secretary, Vice President & General Counsel
• J. Donald Dumas, Vice President-Business Development
• Kevin Daniels, Chief Accounting Officer

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Core Laboratories' key competitors?

Some companies that are related to Core Laboratories include Frank's International (FI), Liberty Oilfield Services (LBRT), Subsea 7 (SUBCY), Oceaneering International (OII), RPC (RES), National Energy Services Reunited (NESR), NexTier Oilfield Solutions (NEX), ProPetro (PUMP), Select Energy Services (WTTR), Helix Energy Solutions Group (HLX), North American Construction Group (NOA), FTS International (FTSI), Ranger Energy Services (RNGR), Natural Gas Services Group (NGS) and Mammoth Energy Services (TUSK).
View all of CLB's competitors.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.54%), Scout Investments Inc. (0.21%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.05%) and Capital Asset Advisory Services LLC (0.04%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC.
View insider buying and selling activity for Core Laboratories or view top insider-selling stocks.

Which major investors are buying Core Laboratories stock?

CLB stock was bought by a variety of institutional investors in the last quarter, including Scout Investments Inc., Capital Asset Advisory Services LLC, State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories or or view top insider-buying stocks.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $30.13.

How much money does Core Laboratories make?

Core Laboratories has a market capitalization of $1.40 billion and generates $487.27 million in revenue each year. The oil and gas company earns $-97.64 million in net income (profit) each year or $0.80 on an earnings per share basis.

How many employees does Core Laboratories have?

Core Laboratories employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

Where are Core Laboratories' headquarters?

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected].